688050 Eyebright Medical Technology (Beijing) Co., Ltd.
- 105.13
- +1.90+1.84%
Eyebright Medical Technology (Beijing) Co., Ltd. News
688050 Aibo Healthcare\'s progress announcement on the repurchase of the company\'s shares through centralized bidding transactions
688050 Aibo Healthcare\'s announcement on the company\'s simple procedures to issue shares to specific targets, dilute immediate returns, and fill return measures and commitments from related entities
Elbonord (Beijing) Medical Technology Co., Ltd. shareholder dividend return plan for the next three years (2024-2026)
Feasibility analysis report on the use of capital raised by Elbonord (Beijing) Medical Technology Co., Ltd. to issue shares to specific targets through simple procedures in 2024
Abonord (Beijing) Medical Technology Co., Ltd.\'s 2024 Stock Issuance Plan Verification and Analysis Report Using Simple Procedures to Specific Targets
Abonord (Beijing) Medical Technology Co., Ltd.\'s 2024 plan to issue shares to specific targets through a simple procedure
688050 Aibo Healthcare\'s indicative announcement on a plan to issue shares to specific targets using a simplified procedure
688050 Aibo Healthcare\'s progress announcement on the repurchase of the company\'s shares through centralized bidding transactions
688050 Aibo Healthcare\'s announcement on the cancellation of the pledge of some shareholders\' shares
688050 Aibo Healthcare\'s announcement on the cancellation of the pledge of some shareholders\' shares
688050 Aibo Healthcare\'s progress announcement on the repurchase of the company\'s shares through centralized bidding transactions
Announcement of Progress on Repurchasing Company Shares by Eyebright Medical Technology (Beijing) Co., Ltd. through Centralized Bidding Trading
Announcement of share pledge by some shareholders of Eyebright Medical Technology (Beijing) Co., Ltd. (stock code: 688050)
Announcement of Progress on Repurchasing Company Shares by Eyebright Medical Technology (Beijing) Co., Ltd. through Centralized Bidding Trading
Announcement of the Progress of the Implementation of the Plan for Shareholding Increase by the Company's Controlling Shareholders, Actual Controllers, Chairman and General Manager, and Some Directors and Senior Management of Eyebright Medical Technology (Beijing) Co., Ltd. (Stock Code: 688050)
Eyebright Medical Technology (Beijing) Co., Ltd. 2021 Restricted Stock Incentive Plan First Granting of Part of the Third Attributed Period and Reserved Granting of Part of the Second Attributed Period Attribution Results and Stock Listing Announcement.
Announcement on Shareholders, Actual Controllers, the Chairman and General Manager, and Certain Directors and Senior Management Personnel of Eyebright Medical Technology (Beijing) Co., Ltd. Increasing Their Shareholding in the Company's Shares
Opinions of the supervisory board of eyebright medical technology (beijing) co., ltd. on the verification of the list of first-time awarded restricted stock incentive plan for the third vesting period and the reserved award list for the second vesting period in 2021.
Announcement on the Adjustment of Grant Price and Quantity of the 2021 Restricted Stock Incentive Plan of Eyebright Medical Technology (Beijing) Co., Ltd.
Beijing Zhong Lun Law Firm's Announcement on the Adjustment of Grant Prices and Quantities, Achievement of the Third Vesting Condition for Partial Initial Grants, Achievement of the Second Vesting Condition for Partial Reserved Grants, and Partial Restricted Stocks of Southern Arch (Beijing) Medical Technology Co., Ltd.'s 2021 Restricted Stock Incentive Plan.
Analysis
Price Target
No Data
No Data